PIRS Pieris Pharmaceuticals Inc Future Profit

Official company branding of Pieris Pharmaceuticals Inc (PIRS)

The search for strategic alliances with industry behemoths defines the development vector of Pieris Pharmaceuticals (PIRS). The company's forward earnings, as shown on this chart from GURU.Markets, demonstrate the impact of the cost of capital, where captures the current value of the indicator. Growth is based on the Anticalin platform and cost optimization, although geopolitical tensions and sanctions seriously hinder the international logistics of components.

pieris.com (PIRS): Expected Net Profit from 07/04/2022 to 11/17/2026

Pieris - analytical breakdowns and key metrics (PIRS)

- share price and consensus valuation forecast:
Fundamental company analysis:PIRS, Pieris Pharmaceuticals, Inc.
Finished products of Pieris Pharmaceuticals Inc

Portfolio managers evaluate the operating model of Pieris Pharmaceuticals (PIRS) through the lens of long-term profitability. This metric identifies systemic business degradation or growth by measuring the expected return on invested capital. By analyzing the projected financial result, an investor determines the asset's real value without market illusions. For Pieris Pharmaceuticals, this forecast is based on the commercialization of stable anticalins for lung therapy. The trend in the projected financial result confirms the company's fundamental stability.

Competitor analysis for Pieris Pharmaceuticals

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Expected Net Income|Projected Future Earnings SPRY (ARS Pharmaceuticals Inc)|Future Net Profit TBPH (Theravance)|AQST - Expected Profit|scPharmaceuticals (SCPH) - Future Profit|TECX: Projected Future Earnings|Net Profit Forecast TNXP|Expected Profit China SXT Pharmaceuticals, Inc.|EPRX: Expected Net Income|Projected Future Earnings BHST|EXOZ - Expected Net Profit|Projected Future Earnings ORMP (oramed.com)|Projected Future Earnings enterabio.com ENTX|HYFT - Expected Profit|Company Profit Forecast ABVC BioPharma, Inc ABVC|CPIX: Projected Future Earnings|Quantum BioPharma Ltd - Expected Net Income|Future Profit FGEN|Telomir Pharmaceuticals, Inc. - Forward Earnings|Projected Future Earnings RANI|SNYR (Synergy CHC) - Expected Net Income|Expected Profit Rallybio RLYB|Lexaria Bioscience (LEXX) - Expected Net Profit|PULM - Expected Profit|Company Profit Forecast Pheton Holdings PTHL|APM (Aptorum) - Future Profit|Lyra Therapeutics, Inc. (LYRA) - Projected Future Earnings|IBO (impactbiomedinc.com) - Projected Future Earnings|TNFA (TNF Pharmaceuticals) - Future Net Profit|Expected Profit cbdmd.com (YCBD)|Company Profit Forecast PainReform Ltd|Projected Future Earnings CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Expected Net Profit|OPTN - Expected Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast